Real-world data provided strong evidence supporting GLP-1 RA use in patients with diabetes receiving dialysis. This Freely Filtered episode discusses metformin termination as explored by target trial emulation. Lifestyle and metformin interventions cut diabetes risk for 21 years in adults with prediabetes, DPP study shows. Tirzepatide linked to reduced muscle fat infiltration and volume in type 2 diabetes, per SURPASS-3 MRI substudy findings. Use of SGLT2i with RAASi is associated with reduced risk for hyperkalemia in the clinical setting, a study found. Chronic hyperglycemia in pediatric type 1 diabetes may impair white matter development; brain changes persist into puberty. An observational study shed light on how family medical history may affect chronic kidney disease (CKD) outcomes. The accuracy of continuous glucose monitoring versus self-monitored blood glucose in hemodialysis patients is not well known. Researchers assessed the landscape of QSP modeling and developed a use case for QSP to determine hyperkalemia risk. Two years after its approval, researchers studied the use of finerenone in adults with type 2 diabetes and CKD. Medicare Part D spending on GLP-1 drugs has soared to $5.7 billion, straining Medicare spending. Current practice guidelines do not address dietary management specific to diabetic kidney disease (DKD). AstraZeneca has removed tozorakimab from its phase 2 pipeline for diabetic kidney disease. Researchers, led by Yehuda Handelsman, conducted a post-hoc analysis of the ATHENA and EURIDIS/ADONIS studies and ... According to Silvia Giovannini and colleagues from the Università Cattolica del Sacro Cuore in Rome, Italy, recent ... Diabetes mellitus (DM) is a common comorbidity in patients with atrial fibrillation (AF) and is associated with an ... Patient frailty is associated with higher prevalence of certain hospital-acquired conditions (HACs) in patients ... A new high-sensitivity cardiac troponin helps predict adverse cardiovascular events in diabetic patients with critical ... Patients with diabetes have a much higher risk of complications following coronary artery bypass surgery compared with ... As vascular-related deaths have declined among patients with diabetes, they are no longer the leading cause of death in ...